Categorical meta-analysis of Osteopontin as a clinical cancer marker
File name : Weber-Lett-2011.pdf View Fullscreen
Nuclear osteopontin-c is a prognostic breast cancer marker
File name : Zduniak-2015.pdf View Fullscreen
Osteopontin splice variants are differential predictors of breast cancer treatment responses
File name : Zduniak-2016.pdf View Fullscreen
Breast cancer risk in papilloma patients
File name : Ziolkowski-2022.pdf View Fullscreen
Breast cancer risk in premalignant lesions
File name : premalignant-lesions-paper-2018-journal-co-cancer.pdf View Fullscreen
Osteopontin and Breast Papilloma
File name : breast-papilloma-BCR-preprint.pdf View Fullscreen